Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection. 2003

Sandra Kao, and Hirofumi Akari, and Mohammad A Khan, and Markus Dettenhofer, and Xiao-Fang Yu, and Klaus Strebel
Laboratory of Molecular Microbiology, Viral Biochemistry Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-0460, USA.

Packaging of the human immunodeficiency virus type 1 Vif protein into virus particles is mediated through an interaction with viral genomic RNA and results in the association of Vif with the nucleoprotein complex. Despite the specificity of this process, calculations of the amount of Vif packaged have produced vastly different results. Here, we compared the efficiency of packaging of Vif into virions derived from acutely and chronically infected H9 cells. We found that Vif was efficiently packaged into virions from acutely infected cells (60 to 100 copies per virion), while packaging into virions from chronically infected H9 cells was near the limit of detection (four to six copies of Vif per virion). Superinfection by an exogenous Vif-defective virus did not rescue packaging of endogenous Vif expressed in the chronically infected culture. In contrast, exogenous Vif expressed by superinfection of wild-type virus was readily packaged (30 to 40 copies per virion). Biochemical analyses suggest that the differences in the relative packaging efficiencies were not due to gross differences in the steady-state distribution of Vif in chronically or acutely infected cells but are likely due to differences in the relative rates of de novo synthesis of Vif. Despite its low packaging efficiency, endogenously expressed Vif was sufficient to direct the production of viruses with almost wild-type infectivity. The results from our study provide novel insights into the biochemical properties of Vif and offer an explanation for the reported differences regarding Vif packaging.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D014771 Virion The infective system of a virus, composed of the viral genome, a protein core, and a protein coat called a capsid, which may be naked or enclosed in a lipoprotein envelope called the peplos. Virus Particle,Viral Particle,Viral Particles,Particle, Viral,Particle, Virus,Particles, Viral,Particles, Virus,Virions,Virus Particles
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D016346 Gene Products, vif Retrovirally encoded accessary proteins that play an essential role VIRUS REPLICATION. They are found in the cytoplasm of host cells and associate with a variety of host cell proteins. Vif stands for "virion infectivity factor". Gene Products, sor,sor Gene Products,vif Gene Products,vif Protein,Gene Product, sor,Gene Product, vif,sor Gene Product,vif Gene Product
D017386 Sequence Homology, Amino Acid The degree of similarity between sequences of amino acids. This information is useful for the analyzing genetic relatedness of proteins and species. Homologous Sequences, Amino Acid,Amino Acid Sequence Homology,Homologs, Amino Acid Sequence,Homologs, Protein Sequence,Homology, Protein Sequence,Protein Sequence Homologs,Protein Sequence Homology,Sequence Homology, Protein,Homolog, Protein Sequence,Homologies, Protein Sequence,Protein Sequence Homolog,Protein Sequence Homologies,Sequence Homolog, Protein,Sequence Homologies, Protein,Sequence Homologs, Protein

Related Publications

Sandra Kao, and Hirofumi Akari, and Mohammad A Khan, and Markus Dettenhofer, and Xiao-Fang Yu, and Klaus Strebel
December 2000, Journal of virology,
Sandra Kao, and Hirofumi Akari, and Mohammad A Khan, and Markus Dettenhofer, and Xiao-Fang Yu, and Klaus Strebel
July 1995, Journal of virology,
Sandra Kao, and Hirofumi Akari, and Mohammad A Khan, and Markus Dettenhofer, and Xiao-Fang Yu, and Klaus Strebel
January 2009, Journal of virology,
Sandra Kao, and Hirofumi Akari, and Mohammad A Khan, and Markus Dettenhofer, and Xiao-Fang Yu, and Klaus Strebel
December 1995, Journal of virology,
Sandra Kao, and Hirofumi Akari, and Mohammad A Khan, and Markus Dettenhofer, and Xiao-Fang Yu, and Klaus Strebel
May 2003, Journal of virology,
Sandra Kao, and Hirofumi Akari, and Mohammad A Khan, and Markus Dettenhofer, and Xiao-Fang Yu, and Klaus Strebel
February 1999, Journal of virology,
Sandra Kao, and Hirofumi Akari, and Mohammad A Khan, and Markus Dettenhofer, and Xiao-Fang Yu, and Klaus Strebel
December 1991, The Journal of experimental medicine,
Sandra Kao, and Hirofumi Akari, and Mohammad A Khan, and Markus Dettenhofer, and Xiao-Fang Yu, and Klaus Strebel
August 2001, Journal of virology,
Sandra Kao, and Hirofumi Akari, and Mohammad A Khan, and Markus Dettenhofer, and Xiao-Fang Yu, and Klaus Strebel
May 1993, Journal of virology,
Sandra Kao, and Hirofumi Akari, and Mohammad A Khan, and Markus Dettenhofer, and Xiao-Fang Yu, and Klaus Strebel
November 1993, Journal of virology,
Copied contents to your clipboard!